Skip to main content
Publication date
2017 05 01
Authors
Mataix-Cols, D Fernandez de la Cruz, L Monzani, B Rosenfield, D Andersson, E Perez-Vigil, A Frumento, P de Kleine, RA Difede, J Dunlop, BW Farrell, LJ Geller, D Gerardi, M Guastella, AJ Hofmann, SG Hendriks, GJ Kushner, MG Lee, FS Lenze, EJ Levinson, CA McConnell, H Otto, MW Plag, J Pollack, MH Ressler, KJ Rodebaugh, TL Rothbaum, BO Scheeringa, MS Siewert-Siegmund, A Smits, JAJ Storch, EA Strohle, A Tart, CD Tolin, DF van Minnen, A Waters, AM Weems, CF Wilhelm, S Wyka, K Davis, M Ruck, C
Group authors
DCS Anxiety Consortium
Author KI Usernames
Andersson, E|eanders Fernandez de la Cruz, L|lorfer Fernández de la Cruz, L|lorfer Frumento, P|paofru Mataix-Cols, D|davmat Perez-Vigil, A|anaper Pérez-Vigil, A|anaper Ruck, C|chrruc Rück, C|chrruc
Pubmed ID
28122091
Journal
JAMA psychiatry
Doctype
Article
KI Connection
Hög
Mesh SV
Agonister för excitatoriska aminosyror Antidepressiva medel Cykloserin Exponeringsterapi Kombinationsterapi Läkemedelssamverkan Människa N-metylaspartat Resultatvärdering (Hälso- och sjukvård) Stressyndrom, posttraumatiskt Tvångssyndrom Ångeststörningar
Mesh EN
Antidepressive Agents Anxiety Disorders Combined Modality Therapy Cycloserine Drug Synergism Excitatory Amino Acid Agonists Implosive Therapy N-Methylaspartate Obsessive-Compulsive Disorder Outcome Assessment (Health Care) Stress Disorders, Post-Traumatic
First date
2017-05-14T10:46:52.918Z